AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

Context Therapeutics offers a compelling long opportunity, with three differentiated bispecific T-cell engagers. Click here ...

Merck MRK boasts more than six blockbuster drugs in its portfolio, with the blockbuster PD-L1 inhibitor Keytruda being the ...

On social media, there are tons of homemade sunscreen tutorials floating around. But can you actually make an effective DIY ...

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named a winner of Fast Company’s 2025 ...

A top aide to Health Secretary Robert F. Kennedy Jr. has built a following by accusing the nation's top medical institutions ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support ...

Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

From Kinder Surprise to pufferfish, discover 12 surprising foods quietly banned in the U.S. and why they’ve been kept off ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...